Whereas various studies support the increased prevalence of FVL and PTG mutation in preeclampsia patients, one study reported that there might possibly be other pathogenic factors playing a role in determining the presentation and complications that these mutations would lead to [62]. The gene discussed is F5; the disease is preeclampsia.